ESR1 and breast cancer: ESPL1 expression was found to be significantly elevated in the more aggressive BC subtypes, including ER–versus ER+, PR–versus PR+, and TNBC versus non-TNBC, as well as in basal-like versus non-basal-like tumors (Supplementary Figures S1B–D).